Initial NPWT Coverage
Coverage requires that both the wound indication criteria and the comprehensive wound program criteria below are met.
ALL of the following
A. Wound is ONE of the following
Diabetic (neuropathic) ulcer/wound
Wagner grade 1 ulcer/wound that has not responded to at least 30 days of other conventional wound treatments.
Wagner grade 2 or higher ulcer/wound that has not responded within 30 days of wound treatment.
Stage III or IV pressure ulcer that has not improved with conventional wound/ulcer treatment of at least 30 days.
Venous or arterial insufficiency ulcer that has not improved with conventional wound/ulcer treatment of at least 30 days.
Post-sternotomy wound or post-surgical mediastinitis.
Open dehisced surgical wound.
Skin graft, flap, or dermal substitute for an acute or chronic wound.
Open fracture, as a bridge to definitive closure when primary closure is not possible after or between debridements.
Post-amputation diabetic wound.
B. Comprehensive wound program includes ALL of the following
Appropriate medical management of the causal or contributing medical condition(s) is in place, such as medical and nutritional management for diabetes or lower-extremity elevation and compression garments/bandages for venous insufficiency.
Nutritional and hydration status have been evaluated and are being managed as appropriate to support optimal wound healing.
Environmental and positional/pressure concerns have been evaluated and addressed as appropriate, including frequent repositioning, offloading, properly fitted devices or braces, and incontinence management.
Smoking status has been evaluated and smoking-cessation assistance/resources have been offered as appropriate.
A comprehensive wound assessment is completed and documented weekly by a licensed medical professional.
Continuation Therapy
The pump rental and NPWT supplies may be approved for 30 days when the initial criteria are met. Continued use beyond 30 days requires an extension request every 30 days with updated wound-assessment documentation for review by the Health Plan Medical Director.
Continued coverage requires ALL of the following
All Initial NPWT Coverage criteria in A and B remain met.
Updated wound-assessment documentation demonstrates progressive wound improvement or healing.
Review the contract and endorsements for exclusions, prior-authorization requirements, and other benefit requirements. NPWT used for a condition or diagnosis other than one listed in the Indications of Coverage is considered experimental, investigational, and unproven to affect health outcomes. When the condition or diagnosis is listed but the coverage criteria are not met, NPWT is considered not medically necessary.
The following are considered experimental, investigational, and unproven to affect health outcomes: single-use, disposable, non-powered, or mechanical NPWT devices, including but not limited to PICO, SNAP, and UNO; NPWT with instillation (NPWTi); the ABTHERA® Open Abdomen Negative Pressure Therapy System; and WoundVision Scout®.
NPWT is also considered experimental, investigational, and unproven for pilonidal disease, cyst, or sinus; partial-thickness burn; infected bypass graft on the lower extremity; necrotizing fasciitis; esophageal perforation or leak; prevention of surgical-site infection; prophylactic use after surgery; or use in conjunction with hyperbaric oxygen therapy or bioengineered skin substitutes.
NPWT is considered not medically necessary when any of the following are present: malignancy or cancer in the wound; untreated soft-tissue infection or osteomyelitis near the wound; necrotic tissue with eschar in the wound; a fistula to an organ or body cavity near the wound; exposed vital structures, including nerves, an anastomotic site, vasculature, or organs; uniform granulation tissue has formed; a closed, clean, non-infected incision; a non-infected cesarean section; or a closed surgical incision following total joint arthroplasty.
More than one NPWT pump billed per individual for the same dates of service or time span is considered not medically necessary, because tubing can typically be bridged between wounds to use one pump. Rental charges exceeding the purchase price of the device may be limited by the applicable health plan.
Up to a maximum of 15 dressing kits per wound per month is considered medically necessary, unless documentation shows that the wound size requires more than one dressing kit for each dressing change.
Up to a maximum of 10 canister sets per month is considered medically necessary, unless documentation shows large-volume drainage exceeding 90 mL of exudate per day. For high-volume exudative wounds, a stationary pump with the largest-capacity canister must be used. Excess canister utilization attributable to equipment failure, rather than excessive drainage volume, is not medically necessary.